(Q46204858)

20 December 2017

title

Organic cation transporters OCT1 and OCT2 determine the accumulation of lamivudine in CD4 cells of HIV-infected patients (English)

1 reference

20 December 2017

1 reference

N Jung

1

1 reference

20 December 2017

C Lehmann

2

1 reference

20 December 2017

A Rubbert

3

1 reference

20 December 2017

E Schömig

4

1 reference

20 December 2017

G Fätkenheuer

5

1 reference

20 December 2017

P Hartmann

6

1 reference

20 December 2017

D Taubert

7

1 reference

20 December 2017

publication date

9 August 2012

1 reference

20 December 2017

number of pages

7

1 reference

inferred from page(s)

published in

Infection

1 reference

20 December 2017

volume

41

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

379-385

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s15010-012-0308-8

exact match

0 references

cites work

Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Lamivudine for the treatment of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Hepatitis B virus and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Mammalian 5'(3')-deoxyribonucleotidase, cDNA cloning, and overexpression of the enzyme in Escherichia coli and mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Mammalian 5'-nucleotidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Drug uptake transporters in antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Organic cation transporters and their roles in antiretroviral drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

VACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0308-8

Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system

21 January 2018

1 reference

12 December 2020

Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs

1 reference

12 December 2020

Cellular nucleoside pharmacokinetics and pharmacology: a potentially important determinant of antiretroviral efficacy

1 reference

12 December 2020

Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese

1 reference

12 December 2020

10.1007/S15010-012-0308-8

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017